Immunology & Inflammation

Evidentis conducts clinical research focused on autoimmune liver disease, inflammatory pathways and immune-mediated conditions that influence liver, metabolic, and related conditions. Our studies evaluate investigational therapies designed to modulate inflammation, regulate immune activity and address immune-driven disease processes.

Conditions We Study

Autoimmune liver disease (AIH, PSC, PBC)

Immune-mediated inflammatory conditions

Inflammatory pathways contributing to liver or metabolic dysfunction

Chronic inflammatory disorders relevant to investigational therapies

Overlap syndromes and mixed inflammatory/metabolic presentations

What Participation May Involve

Study procedures vary by protocol and may include:

Clinic visits and physical assessments

Laboratory testing

Imaging or elastography (when applicable)

Questionnaires

Timed procedures or PK-related workflows (if required by the protocol)

There is no cost to participate. Eligible participants may receive compensation for study-related time and travel.

Confidentiality

Information submitted during screening is confidential and used only to determine potential eligibility for clinical research participation.